{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T20:36:48Z","timestamp":1782765408023,"version":"3.54.5"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,4,14]]},"DOI":"10.7759\/cureus.37584","type":"journal-article","created":{"date-parts":[[2023,4,14]],"date-time":"2023-04-14T18:19:56Z","timestamp":1681496396000},"source":"Crossref","is-referenced-by-count":8,"title":["Effect of Thymectomy on Outcomes of Myasthenia Gravis Patients: A Case-Control Study at a Tertiary Care Hospital"],"prefix":"10.7759","author":[{"given":"Imran","family":"Khawaja","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s00508-012-0258-2","article-title":"Epidemiology of myasthenia gravis in Austria: rising prevalence in an ageing society","volume":"124","author":"Cetin H","year":"2012","unstructured":"Cetin H, F\u00fcl\u00f6p G, Zach H, Auff E, Zimprich F. Epidemiology of myasthenia gravis in Austria: rising prevalence in an ageing society. Wien Klin Wochenschr. 2012, 124:763-8. 10.1007\/s00508-012-0258-2","journal-title":"Wien Klin Wochenschr"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-019-09667-5","article-title":"Frequency and clinical features of treatment-refractory myasthenia gravis","volume":"267","author":"Rath J","year":"2020","unstructured":"Rath J, Brunner I, Tomschik M, et al.. Frequency and clinical features of treatment-refractory myasthenia gravis. J Neurol. 2020, 267:1004-11. 10.1007\/s00415-019-09667-5","journal-title":"J Neurol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1196\/annals.1254.053","article-title":"The epidemiology of myasthenia gravis","volume":"998","author":"Phillips LH 2nd","year":"2003","unstructured":"Phillips LH 2nd. The epidemiology of myasthenia gravis. Ann N Y Acad Sci. 2003, 998:407-12. 10.1196\/annals.1254.053","journal-title":"Ann N Y Acad Sci"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(16)00032-6","article-title":"Myasthenia gravis: subgroup classification and therapeutic strategies","volume":"14","author":"Gilhus NE","year":"2015","unstructured":"Gilhus NE, Verschuuren JJ. Myasthenia gravis: subgroup classification and therapeutic strategies. Lancet Neurol. 2015, 14:1023-36. 10.1016\/S1474-4422(16)00032-6","journal-title":"Lancet Neurol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1602489","article-title":"Randomized trial of thymectomy in myasthenia gravis","volume":"375","author":"Wolfe GI","year":"2016","unstructured":"Wolfe GI, Kaminski HJ, Aban IB, et al.. Randomized trial of thymectomy in myasthenia gravis. N Engl J Med. 2016, 375:511-22. 10.1056\/NEJMoa1602489","journal-title":"N Engl J Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-013-6880-8","article-title":"Thymectomy: role in the treatment of myasthenia gravis","volume":"260","author":"Spillane J","year":"2013","unstructured":"Spillane J, Hayward M, Hirsch NP, Taylor C, Kullmann DM, Howard RS. Thymectomy: role in the treatment of myasthenia gravis. J Neurol. 2013, 260:1798-801. 10.1007\/s00415-013-6880-8","journal-title":"J Neurol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(18)30392-2","article-title":"Long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis: 2-year extension of the MGTX randomised trial","volume":"18","author":"Wolfe GI","year":"2019","unstructured":"Wolfe GI, Kaminski HJ, Aban IB, et al.. Long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis: 2-year extension of the MGTX randomised trial. Lancet Neurol. 2019, 18:259-68. 10.1016\/S1474-4422(18)30392-2","journal-title":"Lancet Neurol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/ene.15362","article-title":"Short-term and sustained clinical response following thymectomy in patients with myasthenia gravis","volume":"29","author":"Rath J","year":"2022","unstructured":"Rath J, Taborsky M, Moser B, et al.. Short-term and sustained clinical response following thymectomy in patients with myasthenia gravis. Eur J Neurol. 2022, 29:2453-62. 10.1111\/ene.15362","journal-title":"Eur J Neurol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(15)00145-3","article-title":"Myasthenia gravis: subgroup classification and therapeutic strategies","volume":"14","author":"Gilhus NE","year":"2015","unstructured":"Gilhus NE, Verschuuren JJ. Myasthenia gravis: subgroup classification and therapeutic strategies. Lancet Neurol. 2015, 14:1023-36. 10.1016\/S1474-4422(15)00145-3","journal-title":"Lancet Neurol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000004341","article-title":"Rituximab as treatment for anti-MuSK myasthenia gravis: multicenter blinded prospective review","volume":"89","author":"Hehir MK","year":"2017","unstructured":"Hehir MK, Hobson-Webb LD, Benatar M, et al.. Rituximab as treatment for anti-MuSK myasthenia gravis: multicenter blinded prospective review. Neurology. 2017, 89:1069-77. 10.1212\/WNL.0000000000004341","journal-title":"Neurology"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/mus.21609","article-title":"Construct and concurrent validation of the MG-QOL15 in the practice setting","volume":"41","author":"Burns TM","year":"2010","unstructured":"Burns TM, Grouse CK, Conaway MR, Sanders DB. Construct and concurrent validation of the MG-QOL15 in the practice setting. Muscle Nerve. 2010, 41:219-26. 10.1002\/mus.21609","journal-title":"Muscle Nerve"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/0003-4975(89)90015-5","article-title":"Transsternal radical thymectomy for myasthe nia gravis: a 15-year review","volume":"47","author":"Hatton PD","year":"1988","unstructured":"Hatton PD, Diehl JT, Daly BD, et al.. Transsternal radical thymectomy for myasthe nia gravis: a 15-year review. Ann Thorac Surg. 1988, 47:438-40. 10.1016\/0003-4975(89)90015-5","journal-title":"Ann Thorac Surg"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-199608000-00017","article-title":"Long-term outcome and quality of life after thymectomy for myasthenia gravis","volume":"224","author":"Busch C","year":"1996","unstructured":"Busch C, Machens A, Pichlmeier U, Emsk\u00f6tter T, Izbicki JR. Long-term outcome and quality of life after thymectomy for myasthenia gravis. Ann Surg. 1996, 224:225-32. 10.1097\/00000658-199608000-00017","journal-title":"Ann Surg"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/0003-4975(94)90993-8","article-title":"Thymectomy for the myasthenia gravis patient: factors influencing outcome","volume":"57","author":"Frist W","year":"1994","unstructured":"Frist W, Thirumalai S, Doehring C, Merril W, Stewart J, Fenichel G, Bender H. Thymectomy for the myasthenia gravis patient: factors influencing outcome. Ann Thorac Surg. 1994, 57:334-8. 10.1016\/0003-4975(94)90993-8","journal-title":"Ann Thorac Surg"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.54.5.406","article-title":"Actuarial analysis of the occurrence of remissions following thymectomy for myasthenia gravis in 400 patients","volume":"54","author":"Durelli L","year":"1991","unstructured":"Durelli L, Maggi G, Casadio C, Ferri R, Rendine S, Bergamini L. Actuarial analysis of the occurrence of remissions following thymectomy for myasthenia gravis in 400 patients. J Neurol Neurosurg Psychiatry. 1991, 54:406-11. 10.1136\/jnnp.54.5.406","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1136\/thx.42.3.199","article-title":"Surgical treatment for myasthenia gravis","volume":"42","author":"Otto TJ","year":"1987","unstructured":"Otto TJ, Strugalska H. Surgical treatment for myasthenia gravis. Thorax. 1987, 42:199-204. 10.1136\/thx.42.3.199","journal-title":"Thorax"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.2147\/NDT.S8915","article-title":"Current and emerging therapies for the treatment of myasthenia gravis","volume":"7","author":"Mantegazza R","year":"2011","unstructured":"Mantegazza R, Bonanno S, Camera G, Antozzi C. Current and emerging therapies for the treatment of myasthenia gravis. Neuropsychiatr Dis Treat. 2011, 7:151-60. 10.2147\/NDT.S8915","journal-title":"Neuropsychiatr Dis Treat"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/119929-effect-of-thymectomy-on-outcomes-of-myasthenia-gravis-patients-a-case-control-study-at-a-tertiary-care-hospital","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:59:20Z","timestamp":1707508760000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/119929-effect-of-thymectomy-on-outcomes-of-myasthenia-gravis-patients-a-case-control-study-at-a-tertiary-care-hospital"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,14]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.37584","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4,14]]}}}